Microbial Flora Drives Interleukin 22 Production in Intestinal NKp46+ Cells that Provide Innate Mucosal Immune Defense  by Satoh-Takayama, Naoko et al.
Immunity
ArticleMicrobial Flora Drives Interleukin 22
Production in Intestinal NKp46+ Cells
that Provide Innate Mucosal Immune Defense
Naoko Satoh-Takayama,1,2 Christian A.J. Vosshenrich,1,2 Sarah Lesjean-Pottier,1,2 Shinichiro Sawa,3 Matthias Lochner,3
Frederique Rattis,4 Jean-Jacques Mention,1,2 Kader Thiam,4 Nadine Cerf-Bensussan,5 Ofer Mandelboim,6 Gerard Eberl,3
and James P. Di Santo1,2,*
1Cytokines and Lymphoid Development Unit, Institut Pasteur, Paris F-75724, France
2Inserm U668, Paris F-75724, France
3Lymphoid Tissue Development Group, Institut Pasteur, Paris F-75724, France
4genOway, Lyon 69362, France
5Inserm U793, Faculte´ de Me´decin Necker, Paris F-75724, France
6The Lautenberg Center for General and Tumor Immunology, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel
*Correspondence: disanto@pasteur.fr
DOI 10.1016/j.immuni.2008.11.001SUMMARY
Natural killer (NK) cells are innate lymphocytes with
spontaneous antitumor activity, and they produce in-
terferon-g (IFN-g) that primes immune responses.
Whereas T helper cell subsets differentiate from na-
ive T cells via specific transcription factors, evidence
for NK cell diversification is limited. In this report, we
characterized intestinal lymphocytes expressing the
NK cell natural cytotoxicity receptor NKp46. Gut
NKp46+ cells were distinguished from classical NK
cells by limited IFN-g production and absence of per-
forin, whereas several subsets expressed the nuclear
hormone receptor retinoic acid receptor-related or-
phan receptor t (RORgt) and interleukin-22 (IL-22). In-
testinal NKp46+IL-22+ cellsweregenerated via a local
process that was conditioned by commensal bacte-
ria and required RORgt. Mice lacking IL-22-produc-
ing NKp46+ cells showed heightened susceptibility
to the pathogen Citrobacter rodentium, consistent
with a role for intestinal NKp46+ cells in immune pro-
tection. RORgt-driven diversification of intestinal
NKp46+ cells thereby specifies an innate cellular de-
fensemechanism that operates at mucosal surfaces.
INTRODUCTION
Natural killer (NK) cells develop from hematopoietic stem cells
under the influence of soluble factors and stromal cell interac-
tions provided in the bone marrow (BM) and thymic microenviron-
ments (Di Santo, 2006). The process of NK cell maturation
involves the sequential acquisition of cell-surface receptors that
provide either activating or inhibitory signals (Lanier, 2005; Raulet
et al., 2001). NK cells are ‘‘educated’’ toward host major histo-
compatibility complex (MHC) class I molecules as their concom-
itantly expressed inhibitory receptors (of the NKG2 and Ly49
families) specific for MHC class I molecules are tested (Gasser
and Raulet, 2006). NK cells that pass this developmental check-958 Immunity 29, 958–970, December 19, 2008 ª2008 Elsevier Inc.point are considered ‘‘competent’’ and acquire diverse functional
capacities, including granule-mediated cytotoxicity and prompt
chemokine and cytokine production (predominantly of inter-
feron-g [IFN-g] and tumor necrosis factor-a [TNF-a]) (Yokoyama
and Kim, 2006). BM and thymus-derived NK cells seed the pe-
ripheral lymphoid organs and primarily localize in the spleen,
lymph node (LN), liver, and lung and in the uterus during gestation
(Huntington et al., 2007). NK cells perform critical functions during
innate and adaptive immune responses, by virtue of their ability to
eliminate virus-infected, transformed, or stressed cells and to
recruit and amplify inflammatory responses (Trinchieri, 1995).
NK cells have been long considered as a homogeneous
population of cytotoxic and cytokine-producing cells. As such,
NK cells may be predicted to perform stereotyped roles during
the immune response, with little flexibility in their biological func-
tions. In contrast, several different T helper (Th) cell subsets (Th1,
Th2, and Th17) differentiate from naive T cells after antigen acti-
vation in a process that is guided by transcription factors and
results in the generation of distinct effector T cells with special-
ized functions (Ho and Glimcher, 2002; Weaver et al., 2007). In
contrast, evidence for a similar level of functional diversification
in the NK cell lineage is limited. Early studies identified phenotyp-
ically distinct human NK cell subsets (Lanier et al., 1986) that
were subsequently shown to have different tissue localizations
and functional properties (Fehniger et al., 2003; Ferlazzo et al.,
2004). Recent observations in the mouse have confirmed the
existence of distinct NK cell subsets (Hayakawa et al., 2006;
Veinotte et al., 2008; Vosshenrich et al., 2006). NK cell subsets
may be generated as a consequence of programming via tran-
scription factors or may represent different stages of an ongoing
process of NK cell differentiation, in which maturing NK cells ex-
hibit unique functional capacities. The mechanisms that control
acquisition of NK cell effector functions are not fully understood,
but they may include signals derived from the environment that
could be altered during infection. One example is the recent
report describing interleukin-10 (IL-10) production by activated
NK cells in the context of chronic Leishmania infection (Maroof
et al., 2008). Collectively, these results challenge the general
notion that NK cells function in a homogeneous fashion as
proinflammatory killer cells.
Immunity
NKp46+ Cells in the Gut Express RORgt and IL-22In the intestinal tract, a coordinated system of hematopoietic
and nonhematopoietic cell types synergize to provide immune
defense against potential ingested pathogens (reviewed in Ar-
tis, 2008). A single cell layer of epithelial cells separates the gut
lumen harboring the commensal flora and food-born pathogenic
antigens from the body. The protective function of epithelial
cells includes not only a primary physical barrier, but also an im-
munoregulatory role via the secretion of antimicrobial peptides,
cytokines, and chemokines that recruit hematopoietic cells.
Additional sensors include intestinal dendritic cells (DCs) that
extend transepithelial dendrites into the intestinal lumen and
sample its contents for signs of infection. Specialized M cells pro-
vide a ‘‘pump’’ that feeds Peyers’ patch DCs with gut antigens to
initiate adaptive immune responses that are tuned toward immu-
noglobin A secretion. Whereas NK cells have been documented
in the intestinal mucosa (Leon et al., 2003; Tagliabue et al., 1982),
the developmental pathways that generate gut NK cells and the
biological roles for intestinal NK cells in mucosal immunity are
not understood. NK cells, by virtue of their rapid cytokine re-
sponse, might play an important role in intestinal immunity by
interfacing with intestinal DCs to regulate the orchestration of
immune responses. Alternatively, NK cells may eliminate
stressed or infected target cells and contribute to epithelial cell
homeostasis.
In this study, we characterized distinct subsets of intestinal
lymphocytes that expressed the natural cytotoxicity receptor
NKp46. We used this molecule as a starting point because
NKp46 has been shown to be highly and specifically expressed
in NK cells (Biassoni et al., 1999; Sivori et al., 1997). Surprisingly,
a substantial subset of NKp46+ cells in the intestine lacked per-
forin and did not transcribe IFN-g, and they thus bore little func-
tional resemblance to classical NK cells. In contrast, these cells
expressed the nuclear hormone receptor retinoic acid receptor-
related orphan receptor gamma t (RORgt) and IL-22 in response
to local microenvironmental signals and were involved in im-
mune defense against the pathogen Citrobacter rodentium.
Our results provide evidence for an intestinal ‘‘niche’’ that condi-
tions the differentiation of diverse NKp46+ cell subsets that
appear to play a role in mucosal immunity.
RESULTS
Identification of Phenotypically Diverse NK Cell Subsets
in the Murine Intestinal Tract
NK cells from several species have been shown to specifically ex-
press the natural cytotoxicity receptor NKp46 (encoded by the
Ncr1 locus) (Biassoni et al., 1999; Gazit et al., 2006; Sivori et al.,
1997; Walzer et al., 2007). In order to facilitate identification of
NKp46+ cells, we studied Ncr1GFP/+ mice on the C57BL/6 back-
ground that harbor a green fluorescent protein (GFP) reporter
driven by the Ncr1 promoter (Gazit et al., 2006). As expected,
CD3NKp46+ cells were present in BM, spleen, thymus, liver,
and lymph nodes (Figure 1A and data not shown). CD3NKp46+
cells were also clearly identified as a subset of lamina propria
lymphocytes (LPLs) and intraepithelial lymphocytes (IELs) in the
small and large intestines of Ncr1GFP/+ mice (Figure 1A). These
cells showed typical lymphocyte morphology with scant cyto-
plasmic differentiation and an overall appearance similar to
splenic NK cells (data not shown). Intestinal CD3NKp46+ cellswere dispersed throughout the lamina propria, were more rarely
found in the intraepithelial position, and were essentially absent
from the region of the intestinal crypts (Figure 1B and data not
shown).
Because CD127 (IL-7Ra) expression has been observed on
thymic NK1.1+ cells and a subset of lymph node NK cells (Vei-
notte et al., 2008; Vosshenrich et al., 2006), we used CD127
and the prototypic NK cell marker NK1.1 (recognizing the C-lectin
NKR-P1C) to further characterize the gut CD3NKp46+ LPL and
IEL populations (Figure 1C). Splenic CD3NKp46+ cells were
predominantly NK1.1+CD127 and uniformly expressed CD122
(IL-2Rb), CD11b, CD49b (DX5), the activating receptors NKG2D
and CD16, and a ‘‘repertoire’’ of MHC-specific CD94 and Ly49
receptors (Figure 1C and data not shown). We noticed that
intestinal CD3NKp46+ cells were far more heterogeneous,
and we could identify three subsets differentially expressing
CD127 and NK1.1 (Figure 1C). The first subset was CD127+
NK1.1 and expressed some NK cell markers (including CD224
[2B4] and low amounts of CD122 and NKG2D), but it was nega-
tive for CD11b, CD49b, CD94, and Ly49A and Ly49D
(Figure 1C). Two NK1.1+ cell subsets (CD127+ and CD127) ap-
pear more like splenic NK cells with expression of NKG2D,
CD94, and CD224 but relatively lower densities of CD49b,
CD11b, CD27, and Ly49 family members (Figure 1C and data
not shown). These different CD3NKp46+ cell subsets were
also numerous in the small intestine IEL compartment and large
intestine lamina propria (Figure S1 available online). Together,
these results reveal substantial phenotypic heterogeneity in gut
CD3NKp46+ cells.
Intestinal NKp46+ Cells Fail to Express Typical NK Cell
Effector Functions
NK cells employ several mechanisms to eliminate stressed or
transformed target cells, including granule-mediated cytotoxicity
and activation of Fas-associated protein with death domain
(FADD)-linked death receptors (Smyth et al., 2002). We therefore
assessed whether intestinal NKp46+ cells showed these typical
NK cell cytotoxicity pathways. Optimal granule-mediated cyto-
toxicity requires the coordinated activity of the pore-forming pro-
tein perforin and a family of granzyme serine proteases (Kagi
et al., 1994; Shresta et al., 1995; Smyth et al., 2005). To assess
the expression of perforin by gut NK cells, we used mice that har-
bor a yellow fluorescent protein (YFP) reporter gene driven by the
perforin promoter (PfpYFP/+ mice). As expected, splenic NK cells
from PfpYFP/+ mice uniformly expressed YFP (Figure 2A). In con-
trast, most intestinal CD3NKp46+ cells from these mice lacked
perforin expression, although a small subset of NK1.1+CD127
cells showed weak YFP expression (Figure 2A). NK cells can in-
duce apoptosis in target cells through activation of FADD-linked
death receptors such as TRAIL-R and Fas. We found that intesti-
nal CD3NKp46+ cells were TRAIL (Figure 2B), and only a minor
population expressed FasL (Figure 2C). Thus, most intestinal
CD3NKp46+ cells lack the critical effector molecules required
for cell-mediated cytotoxicity.
NK cells have the capacity to rapidly secrete a variety of cyto-
kines after activation. In humans and mice, NK cell subsets have
been described that show enhanced cytokine production, in par-
ticular production of proinflammatory Th1 cell cytokines IFN-g
and TNF-a (Huntington et al., 2007). In order to determine theImmunity 29, 958–970, December 19, 2008 ª2008 Elsevier Inc. 959
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NKp46+ Cells in the Gut Express RORgt and IL-22capacity of intestinal NK cells to produce IFN-g, we used mice
that harbor a YFP reporter in the 30-untranslated region of the
Ifng locus (IfngYFP/+ mice) that can identify cells having the poten-
tial for rapid IFN-g production because of a remodeled IFN-g
locus (Stetson et al., 2003). We confirmed that splenic NK cells
in IfngYFP/+ mice demonstrate high YFP expression (Figure 2D),
Figure 1. Intestinal NKp46+ Cells Display Unique Phenotypic Properties
(A) Frequencies of CD3NKp46+ cells (boxed) in the indicated organs in Ncr1GFP/+ C57BL/6 mice.
(B) Immunohistology of small intestine from Ncr1GFP/+ mice stained with anti-GFP (green), CD3 (red), and DAPI (blue). Magnification was 203.
(C) NK1.1 versus CD127 expression on gated CD3NKp46+ splenocytes and lamina propria lymphocytes from the small intestine (SI LPLs). The frequencies of the
gated populations are indicated. Histograms show NK cell markers (shaded area) and isotype control staining (black line). One representative experiment of six is
shown.960 Immunity 29, 958–970, December 19, 2008 ª2008 Elsevier Inc.
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NKp46+ Cells in the Gut Express RORgt and IL-22consistent with their IFN-g-producing potential (Figure 2E). In
contrast, intestinal CD3NKp46+ cell subsets showed distinct
patterns of YFP expression, with most CD127+ cells appearing
incompetent for IFN-g production, whereas the CD127 subset
had YFP expression similar to that of splenic NK cells. Collec-
tively, these results indicated that most intestinal NKp46+ cells
were functionally distinct from splenic NK cells.
Figure 2. Intestinal NKp46+ Cells Lack Typical NK Cell
Effector Functions
(A) GFP expression amounts (shaded area) in spleen NK cells
and intestinal CD3NKp46+ cell subsets from the SI LPLs of
PfpYFP/+ reporter mice: CD127+NK1.1 (left), CD127+NK1.1+
(middle), and CD127NK1.1+ (right). Nontransgenic cells are
shown as control (black line).
(B and C) TRAIL expression (B) and FasL expression (C) on
CD3NKp46+ cells from spleen and SI LPLs. Shaded histo-
grams show specific staining (isotype control indicated by
a solid line). The percentages of positive cells are indicated.
(D) YFP expression amounts (shaded area) in spleen NK cells
and intestinal CD3NKp46+ cell subsets from the SI LPLs of
IfngYFP/+ mice: CD127+NK1.1 (left), CD127+NK1.1+ (middle),
and CD127NK1.1+ (right).
(E) Intracellular detection of IFN-g by gated CD3NKp46+ cells
from spleen (left) and SI LPLs (right). Histogram overlays show
percentages of positive cells in nonstimulated cultures
(shaded) or after 4 hr stimulation (solid line). One representa-
tive experiment of three is shown.
Intestinal NKp46+ Cells Express
the Transcription Factor RORgt
and Produce IL-22
To gain more insight into the potential relationship
of intestinal NKp46+ cells to known NK cell subsets
and to help identify their potential effector func-
tions, we compared their transcription factor (TF)
profiles. Several TFs are critical for NK cell devel-
opment in the BM and thymus (including Id2,
GATA-3, PU.1, and Ikaros), whereas others modu-
late their differentiation into cytokine-producing
killer cells (T-bet, GATA-3, IRF-2, MEF, and
CEBP-g) (Di Santo, 2006). CD3NKp46+ cells, irre-
spective of their origin, expressed transcripts for
Id2 but were negative for Foxp3 (Figure 3A and
data not shown). Tbx21 (T-bet) expression was
only observed in splenic NK cells, whereas Gata3
expression was similar in NK cells from the spleen
and gut (Figure 3A). Strikingly, a subset of intestinal
CD3NKp46+ cells expressed the nuclear hormone
receptor RORgt encoded by Rorc. We confirmed
RORgt expression in intestinal NKp46+ cells by
using recently described bacterial artificial chro-
mosome (BAC) transgenic mice harboring a GFP
reporter under the control of the Rorc promoter
(Lochner et al., 2008). In Rorc-GFP mice, GFP
expression was found in intestinal NKp46+ cells ex-
pressing CD127 (both in the LPL and IEL), whereas
NK1.1+ NK cells lacking CD127 (in the intestine
or elsewhere) were essentially GFP (Figure 3B).
Interestingly, almost all CD127+NK1.1 cells were
GFP+ compared with CD127+NK1.1+ cells that only harbored
a fraction (approximately 40%) of RORgt+ cells (Figure 3B). Im-
munohistology confirmed that CD3NKp46+RORgt+ cells were
located primarily as scattered cells in the intestinal LP and
were rare in the cryptopatches at the base of the villi (Figure 3C).
We next assessed whether differential RORgt expression by
intestinal NKp46+ cells had any impact on their functionalImmunity 29, 958–970, December 19, 2008 ª2008 Elsevier Inc. 961
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NKp46+ Cells in the Gut Express RORgt and IL-22properties. By comparing GFP expression with NK1.1 expres-
sion in Rorc-GFP mice, we could clearly identify NKp46+ cell
subsets that expressed distinct amounts of RORgt (Figure 3D).
NKp46+ cells expressing the highest amount of RORgt were es-
sentially NK1.1 (and uniformly expressed CD127; Figure 3B). As
such, this NKp46+CD127+NK1.1 cell subset may be related to
the previously described RORgt+ lymphoid tissue inducer (LTi)
cells known to orchestrate development of programmed sec-
ondary and induced tertiary intestinal lymphoid aggregates
(Eberl and Littman, 2004; Mebius, 2003). LTi cells express CD4
and reside in cryptopatches, which are structures found be-
tween intestinal crypts (Eberl, 2007; Ivanov et al., 2006a). Be-
cause NKp46+CD127+NK1.1 cells are CD4 (data not shown)
and are not observed near the intestinal crypts (Figures 1B and
3C), they appear to differ from LTi cells that also express high
amounts of RORgt (Eberl et al., 2004). The developmental or
functional relationship of the NKp46+RORgthi cells that we
have identified to the previously described LTi cells is unclear.
Nevertheless, NKp46 expression by RORgthi cells could caution
against the use of this marker in a ‘‘universal definition’’ of NK
cells (Walzer et al., 2007).
NKp46+ cells expressing intermediate amounts of RORgt were
essentially NK1.1+ (Figure 3D) and coexpressed CD127 (Fig-
ure 3B), whereas NKp46+ cells that were RORgt were essentially
NK1.1+ (Figure3D).Thus, twodifferentNKp46+ populationsofcells
expressing different amounts of RORgt+ are present in the gut.
RORgt is an essential orchestrator of the Th17 cell pathway
(Ivanov et al., 2007). We therefore compared steady-state expres-
sion profiles of IL-17-family cytokines and other cytokines in
splenic NK cells with intestinal CD3NKp46+ cells that expressed
different amounts of RORgt (Figure 3E). Curiously, intestinal
NKp46+RORgt+ cells failed to express the signature cytokine
IL-17A, although they expressed transcripts for the cytokines
IL-17F and IL-22 (Figure 3E). Unlike splenic NK cells, intestinal
NKp46+CD127+ subset cells also constitutively expressed tran-
scripts for Csf2 (encoding granulocyte-macrophage colony-stim-
ulating factor [GM-CSF]) and the chemokine Cxcl2 with amounts
that positively correlated with RORgt expression (Figure 3E). Il22
expression could also be induced in intestinal LPL after activation
in vitro (Figure 3F). Collectively, these results identify unique func-
tional attributes of intestinal NKp46+ cell subsets that express
RORgt and transcribe genes encoding GM-CSF, Cxcl2, and IL-22.
Developmental Pathways that Generate Intestinal
NKp46+ Cell Subsets
We next sought to identify the signals that control the develop-
ment and functional diversification of intestinal NKp46+ subsets.
Because intestinal NKp46+ cells share some phenotypic similar-ities (CD127+, GATA-3+, and CD11blo) with thymus-derived NK
cells (Vosshenrich et al., 2006), we determined whether they
were related. We found normal numbers and distribution of in-
testinal CD3NKp46+ cells in nude mice lacking the transcription
factor Foxn1 (Figures 4A and 4B), suggesting that gut NKp46+
cell subsets are thymus independent. Intestinal CD3NKp46+
cells also normally developed in the absence of antigen-receptor
recombinase Rag2 (see below).
IL-15 plays an essential role in the development, survival, and
differentiation of NK1.1+ cells (Vosshenrich et al., 2005). Analysis
of Il15/ mice confirmed a similar cytokine dependency of
intestinal NKp46+NK1.1+ cells (Figures 4A and 4B). Interestingly,
the absolute numbers of gut NKp46+CD127+NK1.1 cells were
unaffected by the absence of IL-15, suggesting that the homeo-
stasis of NKp46+ cells that differentially express NK1.1 may be
controlled independently.
Because RORgt plays an important role in the differentiation of
Th17 lineage (Ivanov et al., 2006b), we assessed whether RORgt
was critical for the development and differentiation of gut
NKp46+ cell subsets by using Rorc/ mice (Eberl et al., 2004).
Strikingly, percentages and absolute numbers of intestinal
NKp46+CD127+NK1.1 cells were strongly decreased in the
absence of RORgt (Figures 4B and 4C). In contrast, homeostasis
of intestinal NKp46+NK1.1+ cells appeared unaffected inRorc/
mice (Figures 4B and 4C).
The intestine is in constant contact with commensal microor-
ganisms, which impacts on the development of gut lymphoid
structures and local intestinal immune responses (Artis, 2008;
Bouskra et al., 2008). We next assessed whether microbial stim-
ulation was involved in the homeostasis of gut NKp46+ cell
subsets. In germ-free mice, we found that absolute numbers of
intestinal NKp46+CD127+NK1.1 cells were strongly decreased,
whereas NKp46+NK1.1+ cells were unaffected (Figures 4B and
4C). The similar effects of RORgt deficiency and elimination of
commensal flora on NKp46+CD127+NK1.1 cells suggests that
these processes are linked. Collectively, these results suggest
that homeostasis of intestinal NKp46+ cells that differentially ex-
press NK1.1 is controlled by unique mechanisms, with NK1.1
cells being predominantly maintained through signals derived
from interactions with commensal flora, whereas NK1.1+ cells
are maintained through availability of IL-15.
Signals that Control Il22 Transcription in Intestinal
NKp46+ Cell Subsets
Homeostasis of NKp46+NK1.1+ cells was unaffected by absence
of RORgt or elimination of commensal flora (Figure 4B and 4C),
and we wondered whether Il22 transcription in NKp46+NK1.1+
cells (essentially the CD127+ subset; Figure 3E) was alsoFigure 3. Intestinal NKp46+ Cell Subsets Express Rorc and Il22
(A) TF expression of sorted splenic and intestinal CD3NKp46+ cells. The indicated TFs were analyzed by qPCR, and the expression is normalized toGapdh. N.D.,
not detected.
(B) GFP expression amounts (shaded area) in CD127+NK1.1 (left), CD127+NK1.1+ (middle), and CD127NK1.1+ (right) subsets of intestinal CD3NKp46+ cells
and BM, spleen, liver, and LN CD3NKp46+ cells from Rorc-GFP mice.
(C) Tissue section of small and large intestines from Rorc-GFP stained with anti-GFP (green), NKp46 (red), and CD3 (white). Nuclei were stained with DAPI (blue).
Arrowheads point to CD3NKp46+RORgt+ cells. Magnification was 403.
(D) RORgt versus NK1.1 expression in NKp46+CD3 cells from SI LPLs of Rag2/ 3 Rorc-GFP mice.
(E) Detection of indicated cytokine transcripts by qPCR in NK1.1RORgt+ cells (gray bars), NK1.1+RORgt+ cells (black bars), and NK1.1+RORgt cells (stipled
bars) in NKp46+ cells from the SI LPLs of Rag2/ 3 Rorc-GFP mice compared with splenic NK1.1+ cells (open bars).
(F) Steady-state and PMA plus ionomycin-induced Il22 expression from the SI LPLs of untreated Rag2/ mice. One representative experiment of two is shown.Immunity 29, 958–970, December 19, 2008 ª2008 Elsevier Inc. 963
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NKp46+ Cells in the Gut Express RORgt and IL-22Figure 4. Intestinal IL-22 Production in
NKp46+ Cell Is Driven by Commensal Flora
and Requires RORgt
(A) CD127 versus NK1.1 profiles of gated
CD3NKp46+ cell subsets from SI LPLs from
WT, Foxn1/, and Il15/ mice. The frequencies
of the subsets are indicated.
(B) Absolute numbers of CD3NKp46+ cell sub-
sets from SI LPLs from indicated mice. Results
are means ± standard deviation (SD) from n = 4–6
mice of each genotype.
(C) CD127 versus NK1.1 profiles of gated
CD3NKp46+ cell subsets from SI LPLs from
WT, Rorc/, and germ-free mice (GF).
(D) Il22 and Rorc expression in isolated
CD3NKp46+NK1.1+CD127+ cells from SI LPLs
of WT, Rorc/, and germ-free mice. N.D., not
detected.
(E) RORgt (GFP) expression on intestinal
NKp46+NK1.1+CD127+ cells from SI LPLs of WT,
IL-6-deficient, and IL-12Rb1-deficient Rorc-GFP
mice. The frequencies of GFP-expressing cells
are indicated.964 Immunity 29, 958–970, December 19, 2008 ª2008 Elsevier Inc.
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NKp46+ Cells in the Gut Express RORgt and IL-22Figure 5. Mouse Models to Identify Roles for Intestinal NKp46+ Cell Subsets
(A) Steady-state Il22 expression from total SI LPLs of untreated Rag2/ and Rag2/Il2rg/ mice.
(B) CD127 versus NK1.1 profiles on gated NKp46+ cells of SI LPLs from untreated Rag2/ (left), Rag2/Il2rb/ (center), and Rag2/Il2rg/ mice (right).
(C) Steady-state Il22 transcripts from sorted NK1.1+CD127 and NK1.1+CD127+ subsets of intestinal NKp46+ cells from SI LPLs of untreated Rag2-/-, Rag2/
Il2rb/, and Rag2/Il2rg/ mice. N.D., not detected.independent of these signals. Strikingly, Il22 expression was un-
detectable in NKp46+CD127+NK1.1+ cells from germ-free and
Rorc/ mice (Figure 4D). Moreover, NKp46+CD127+NK1.1+
cells from germ-free mice failed to express RORgt (Figure 4D),
potentially explaining the lack of IL-22 transcription.
Induction of RORgt and subsequent expression of Th17 cell-
like cytokines in differentiating T cells is conditioned by several
soluble factors, including IL-6, IL-23, and TGF-b (Weaver et al.,
2007). We found that IL-6 and IL-23 were not required for the dif-
ferentiation in vivo of intestinal NK1.1+ cells that constitutively ex-
press RORgt and IL-22 (Figure 4E and data not shown). Moreover,
these factors could not induce RORgt expression in splenic NK
cells in vitro (data not shown), although they may amplify Il22 ex-
pression under certain conditions. Together, these results identify
substantial phenotypic and functional diversity within the intesti-
nal NKp46+ cell compartment, with an important role for bacterial
flora in driving development of IL-22+ cells via RORgt.
Relative Roles of Distinct IL-22+ NKp46+ Subsets during
C. rodentium Infection
Infection by C. rodentium causes acute colitis in mice (Schauer
and Falkow, 1993). IL-22 is essential in the early host defense
against C. rodentium and is required for epithelial cell secretion
of several classes of antimicrobial factors (Wolk et al., 2004;Wolk et al., 2006; Zheng et al., 2008). Previous studies using
C. rodentium-induced colitis demonstrated that mucosal IL-22
was retained in mice lacking B cells and T cells (Rag2/
mice). DCs were proposed as IL-22 producers on the basis of
CD11c and IL-22 coexpression by immunohistology, whereas
NK cells were excluded on the basis of the absence of CD49b
and IL-22 costaining (Zheng et al., 2008). Our identification of
IL-22+ NKp46+ cells in the intestine (Figure 3E) that were mostly
CD49b (Figure 1C) yet expressed CD11c (Figure S2) suggested
that these cells might represent the previously identified IL-22
producers (Zheng et al., 2008).
We found that intestinal Il22 transcripts were strongly reduced
in the LPLs of mice deficient in both Rag2 and the common g
chain (Rag2/Il2rg/ mice; Figure 5A), confirming the previous
observations on the role of gc-dependent signals in IL-22
production (Aujla et al., 2008). We suspected that absence of
Il22 expression in Rag2/Il2rg/ mice might not be due solely
to the absence of intestinal NK1.1+ cells, given that
NKp46+CD127+NK1.1 cells that constitutively transcribe Il22
could develop in the absence of IL-15 (Figure 4A). In order to
test this hypothesis, we studied mice deficient in both Rag2
and the IL-2Rb chain that is required for IL-2 and IL-15 signaling
(Rag2/Il2rb/ mice). We predicted that these mice would lack
NK1.1+ cells in the gut yet retain NKp46+CD127+NK1.1 cellsImmunity 29, 958–970, December 19, 2008 ª2008 Elsevier Inc. 965
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NKp46+ Cells in the Gut Express RORgt and IL-22that could produce IL-22. Rag2/Il2rb/ mice would provide
a means of potentially defining the relative roles for IL-22 produc-
tion from distinct NKp46+ subsets in the context of an intestinal
bacterial infection by C. rodentium.
We first compared development of intestinal NKp46+ cell
subsets in LPLs isolated from Rag2/, Rag2/Il2rb/, and
Rag2/Il2rg/ mice. We found that NKp46+NK1.1+ cells were
essentially absent from both Rag2/Il2rb/ and Rag2/
Il2rg/ mice, whereas NKp46+CD127+NK1.1 cells were pres-
ent in Rag2/Il2rb/ mice, but not Rag2/Il2rg/ mice
(Figure 5B). Thus, Rag2/Il2rb/ mice selectively lacked intes-
tinal NKp46+ cells that express NK1.1. Compared to that in
Rag2/ mice, expression of intestinal Il22 was reduced in
Rag2/Il2rb/ mice and further reduced in Rag2/Il2rg/
mice lacking all NKp46+ cells (Figure 5C). Concerning DC devel-
opment in these mice, we found no differences in the distribution
of different DC subsets in mice with or without Il2rg (Figure S2).
DCs fail to express Rorc (Figure S3A), which is required for Il22
transcription in lymphocytes (Ivanov et al., 2006b). Moreover,
we found that isolated intestinal macrophages and DCs did not
express Il22 (Figure S3B). These results suggest that NKp46+
cells represent an important source of IL-22 in the intestine.
We next infected Rag2/, Rag2/Il2rb/, and Rag2/
Il2rg/ mice with C. rodentium, which requires intestinal IL-22
for its control (Zheng et al., 2008). Rag2/Il2rg/ mice were
extremely susceptible to C. rodentium, with all mice showing
dramatic weight loss and succumbing to infection by day 7 (Fig-
ures 6A and 6B). In contrast, both Rag2/Il2rb/ and Rag2/
mice resisted early infection, suggesting that in the absence of
NKp46+NK1.1+ cells, intestinal NKp46+CD127+NK1.1 cells
may provide sufficient IL-22 to protect against C. rodentium. Al-
though percentages and absolute numbers of colonic NKp46+
cell subsets were not substantially altered in response to
C. rodentium (Figures 6C and 6D), we found that Il22 expression
was upregulated in NKp46+ cells after infection (Figure 6E). IL-22
protein was present in supernatants from cultured colonic LPLs
from C. rodentium-infected (day 4) Rag2/ mice (86 pg/ml) and
Rag2/Il2rb/ mice (99 pg/ml), but not from similarly infected
Rag2/Il2rg/ mice. Collectively, these results suggest that
NKp46+CD127+RORgt+ cells are an important source of IL-22
and may act as a mucosal cellular effector in the protection
against C. rodentium.
DISCUSSION
The presence of NK cells in lymphoid as well as nonlymphoid
tissues raises questions as to their specific functional roles at
these different sites. Although intestinal NK cells have been iden-
tified in both humans and rodents (Eiras et al., 2000; Leon et al.,
2003; Tagliabue et al., 1982), previous studies have emphasized
the capacity of these cells to perform ‘‘classical’’ NK cell func-
tions (cytotoxicity and IFN-g production) (Eiras et al., 2000;
Leon et al., 2003; Tagliabue et al., 1982). In this report, we
have re-examined intestinal NK cells in mice. As the starting
point, we analyzed intestinal cells that express the natural cyto-
toxicity receptor NKp46 because this molecule has been shown
to be highly and specifically expressed in NK cells as opposed to
other cells within the hematopoietic system (Biassoni et al.,
1999; Gazit et al., 2006; Sivori et al., 1997; Walzer et al., 2007).966 Immunity 29, 958–970, December 19, 2008 ª2008 Elsevier Inc.We uncovered an unexpected diversity of NKp46+ cells, and
we identified and characterized NKp46+ subsets distinguished
by their differential expression of CD127 and NK1.1 in the small
and large intestine lamina propria and intraepithelial compart-
ments. Whereas one subset (NK1.1+CD127) appeared to repre-
sent ‘‘typical’’ NK cells, NKp46+CD127+ subsets in the gut were
unusual, with an absence of cytotoxic effectors (perforin, gran-
zymes, FasL, and TRAIL), low or absent IFN-g production, ex-
pression of the transcription factor RORgt, and expression of
IL-22. Because RORgt+ IL-22+ NKp46+ cells were not identified
outside the gut and were conditioned by commensal flora, we
propose that the intestine provides a specific ‘‘niche’’ favoring
the development and differentiation of NKp46+ cell subsets
that have particular functional properties. These observations
raise questions about the developmental origins of intestinal
NKp46+ cells, the signals and molecular mechanisms that gener-
ate their functional diversity, and their biological roles in mucosal
immunity.
We investigated the relationship between different intestinal
NKp46+ cell subsets by using a series of mouse mutants that
have altered NK cell development. IL-15 is an essential growth
and differentiation factor for innate lymphocytes and plays a crit-
ical role in the homeostasis of NK1.1+ cells (Cooper et al., 2002;
Ranson et al., 2003; Vosshenrich et al., 2005). IL-15 ablation re-
duced absolute numbers of intestinal NK1.1+ cells by more than
90%. Interestingly, the NKp46+ cells that are CD127+NK1.1
were unaffected by the absence of IL-15, a result that could be
explained if NKp46+CD127+NK1.1 cells were IL-15-indepen-
dent precursors to NK1.1+ gut cells. A similar scenario exists
during NK cell development, in which NK cell precursors
normally develop in the absence of IL-15, but their subsequent
development requires this cytokine (Vosshenrich et al., 2005).
It is interesting to note that NKp46+CD127+NK1.1 cells express
high amounts of RORgt, similar to CD4+CD3 fetal LTi cells that
have NK cell-precursor activity (Mebius et al., 1997). As such,
different gut NKp46+ subsets could represent stages in a linear
differentiation program driven by IL-15.
Alternatively, intestinal NKp46+ cell subsets may be develop-
mentally unrelated. Gut CD127+NK1.1- cells and NK1.1+ cells
could represent distinct hematopoietic lineages despite their
common expression of several NK cell markers (NKp46,
NKG2D, and 2B4). A relationship of gut NKp46+CD127+NK1.1
cells to RORgt+ LTi cells that is independent of any NK cell-pre-
cursor activity is possible. Still, gut NKp46+CD127+NK1.1 cells
do not appear simply as a subset of LTi cells that express NKp46
because these NKp46+ gut cells are not clustered in crypto-
patches and they lack markers associated with LTi, including
CD4 and CD117. Future studies will be necessary to define the
lineage relationships between these diverse NKp46+ cell subsets
in the intestine.
Intestinal NKp46+ cells are distinguished by their expression of
the transcription factor RORgt and IL-22. Previous studies have
shown that RORgt is essential for the generation of differentiated
T cells that express IL-17A (Th17 cells) that play a role in promot-
ing inflammatory immune responses at mucosal surfaces (Ivanov
et al., 2006b). Th17 cells produce an unusual set of cytokines, in-
cluding IL-17A, IL-17F, IL-22, and varying degrees of IFN-g and
IL-10 (Chen and O’Shea, 2008; Stockinger and Veldhoen, 2007;
Weaver et al., 2007). Th17 cell differentiation is controlled via
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STAT3 to induce RORgt expression (Chen and O’Shea, 2008;
Stockinger and Veldhoen, 2007; Weaveret al., 2007). It was there-
fore important to know whether gut NKp46+ cells differentiated in
a manner analogous to Th17 cells. Unlike RORgt+ Th17 cells, we
found that RORgt+ NKp46+ cells did not express IL-17A (and only
were only weakly IL-17F+), whereas they strongly expressed
IL-22. Moreover, IL-6 and IL-23 were not required for develop-
ment of intestinal RORgt+NKp46+ cells, unlike that of Th17 cells
(Chen and O’Shea, 2008; Stockinger and Veldhoen, 2007;
Weaver et al., 2007). Still, IL-23 could boost IL-22 production
from gut NKp46+ cells (N.S.-T. and J.P.D., unpublished data).
Figure 6. Il22 Expression by Intestinal NKp46+ Cells Is Involved in Mucosal Immunity
(A and B) Survival (A) and clinical score (B) of Rag2/ (circles), Rag2/Il2rb/ (squares), and Rag2/Il2rg/ mice (triangles) after C. rodentium infection.
Clinical score was calculated as described in Experimental Procedures.
(C and D) Frequencies (C) and absolute numbers (D) of NKp46+ cell subsets from colonic LPLs from mock and C. rodentium-infected Rag2/ mice. Results are
means ± SD from n = 4 mice (control or infected).
(E) IL-22 expression from colonic NKp46+ subsets of C. rodentium-infected Rag2/ mice.Immunity 29, 958–970, December 19, 2008 ª2008 Elsevier Inc. 967
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NKp46+ Cells in the Gut Express RORgt and IL-22Thus, the mechanisms that control Th17-family cytokine expres-
sion in NKp46+RORgt+ cells appear to differ from those operating
in Th17 cells.
We provide evidence that the functional properties of intestinal
NKp46+ cells are conditioned by commensal flora. In germ-free
mice, NKp46+RORgt+IL-22+ cells are strongly reduced, suggest-
ing that an environmental niche, operative in the gut, generates
these unique effector cells. Commensal organisms impact on
intestinal immunity through numerous complex mechanisms
(Artis, 2008). Bacterial flora is sensed by pattern-recognition
receptors (TLR, NLR, and NALP) on both epithelial cells and
hematopoietic cells and relay signals that result in elaboration
of factors that ‘‘tune’’ gut lymphoid structures (Bouskra et al.,
2008). Preliminary experiments show that intestinal NKp46+ cell
subsets are unaltered in Myd88/ mice (N.S.-T. and J.P.D.,
unpublished data) suggesting that multiple sensors may be in-
volved. Recent data has demonstrated that bacterially produced
ATP can directly augment Th17 differentiation (Atarashi et al.,
2008), whereas commensal flora may inhibit this pathway via
IL-25 (Zaph et al., 2008). How signals derived from bacterial flora
control RORgt and IL-22 in gut NKp46+ cells remains to be
defined, but both direct and indirect mechanisms could be
operative.
We used the C. rodentium-infection model to assess a role for
gut NKp46+ cells in mucosal immune defense. Previous studies
showed that IL-17A was dispensable during the early phase of
C. rodentium infection, whereas IL-22 from a T cell- and B cell-in-
dependent cellular source was essential for survival (Zheng et al.,
2008). IL-22 appeared critical for the maintenance of epithelial
cell integrity and for the secretion of antimicrobial peptides
(b-defensins, RegIII and S100 family members, and lipocalin2)
that counteract bacterial invasion. We found that Rag2/
Il2rg/ mice showed reduced steady-state IL-22 in the intestine
that correlated with heightened susceptibility to C. rodentium,
similar to Il22/ mice (Zheng et al., 2008). In contrast, Rag2/
Il2rb/ mice lacking only the NK1.1+ subset of gut NKp46+ cells
were able to resist C. rodentium, suggesting that production of
IL-22 by intestinal NKp46+CD127+NK1.1 cells may play an im-
portant role in bacterial control. Strong constitutive Il22 expres-
sion by gut NKp46+ cells distinguishes these cells from intestinal
macrophages and DCs that do not express Il22. Although we do
not rule out the possibility that the gc mutation may eliminate
other cell types capable of IL-22 production in response to
C. rodentium, the heightened IL-22 expression by intestinal
NKp46+CD127+NK1.1 cells suggests that these cells are
pivotal.
Expression of IL-22 (but not IL-17A) by gut NKp46+RORgt+
cells indicates biological roles that differ from previously
described mucosal Th17 cells. Although IL-17A is dispensible
during early C. rodentium infection (Zheng et al., 2008), it is nec-
essary for bacterial clearance (Mangan et al., 2006). IL-17A
expression is reduced in C. rodentium-infected Rag2/ mice
(Zheng et al., 2008), and a chronic state of infection is established
that finally leads to death (Vallance et al., 2002). Nevertheless,
despite bacterial persistence at later stages of infection, colon
tissue of C. rodentium-infected Rag2/ mice showed few signs
of tissue destruction (Mangan et al., 2006; Vallance et al., 2002).
This contrasts with C. rodentium infection in Il22/ mice, in
which compromised barrier function allowed systemic bacterial968 Immunity 29, 958–970, December 19, 2008 ª2008 Elsevier Inc.spread (Zheng et al., 2008). These results point to a noninnate cel-
lular source of IL-17A required for elimination of C. rodentium,
with Th17 cells as the likely candidate. IL-17A-producing Th17
cells are present in the intestine of C. rodentium-infected mice
and are required for C. rodentium clearance (Mangan et al.,
2006). Our results reinforce the functional dichotomy of IL-17A
and IL-22 action in the gut: IL-22 is required early to maintain
epithelial cell integrity and prevent bacteria spread, whereas
proinflammatory IL-17A is required later for complete bacterial
clearance. We suggest that intestinal NKp46+ cells could provide
the rapid, innate source of IL-22, whereas adaptive Th17 cells
would furnish IL-17A.
The total surface of intestinal mucosa is estimated to be
>100 m2 in humans and harbors >80% of all immune cells (Artis,
2008). Given that the intestine harbors an estimated 1014 com-
mensal bacteria, it is logical that several elaborate mechanisms
have evolved to sustain the mucosal epithelium and to generate
immune responses upon intestinal epithelial stress or breech. A
crosstalk between NKp46+RORgt+IL-22+ cells and the intestinal
epithelia provides a system whereby these NKp46+ cells may
improve epithelial barrier function and in which perturbations in
intestinal epithelial continuity can be decoded and translated
to an appropriate innate immune response. The reactivity af-
forded by a dedicated and specific NKp46+ cell-based system
may provide a rapid means of protecting mucosal surfaces un-
der diverse conditions.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were purchased from Janvier. Athymic C57BL/6 nude mice
deficient in Foxn1 were provided by the De´partement de Cryopre´servation,
Distribution, Typage et Archivage Animal (CTDA), and germ-free C57BL/6
mice were obtained from the Institut National de la Recherche Agronomique
(INRA). Mice bearing fluorescent reporters driven by Rorc and deficient in Il6
or Il12rb1 (Lochner et al., 2008) or driven by Ifng (Stetson et al., 2003), as
well as mice deficient in Il15, Rag2, Rag2 and Il2rb, Rag2 and Il2rg (Vosshen-
rich et al., 2005; Vosshenrich et al., 2007), or Rorc (Eberl et al., 2004), have
been described. PfpYFP/+ mice were generated by inserting an IRES-eYFP cas-
sette into the murine Pfp 30 untranslated region (exon 3) in C57BL/6 embryonic
stem cells (K.T. et al., unpublished data). All mice were housed in specific path-
ogen-free animal facilities at the Institut Pasteur and were analyzed between 6
and 12 weeks of age in accordance with regulations of the French authorities.
Cell Isolation and Flow Cytometry
IELs were isolated with 0.5 mM EDTA and gentle agitation. After removal of
any residual epithelium, LPLs were isolated with collagenase digestion as
described (Lochner et al., 2008). All antibodies were purchased from BD Phar-
Mingen or eBiosciences. Immunofluorescence analysis (BD FACS Canto II)
was done as described (Vosshenrich et al., 2007).
RNA Isolation and Gene Expression Analysis
RNA was isolated from purified lymphocyte preparations with the RNAeasy
Micro Kit (QIAGEN) and converted to cDNA with Superscript III Reverse
Transcriptase (Invitrogen). In some cases, total RNA was amplified with the
Message Booster Kit (Epicenter Biotechnologies). Quantitative PCR was
performed with gene-specific primers and Th17 RT2 Profiler PCR Array (Super-
Array Bioscience Corporation).
Infection with Citrobacter rodentium
Mice were fasted for 8 hr and gavaged with 2 3 109 CFU of the C. rodentium
strain CDC 1843-73 (ATCC 51116; American Type Culture Collection) before
resuming normal feeding ad libitum. Mice were weighed daily and monitored
for diarrhea and bloody stool. A clinical score was calculated as follows: no
Immunity
NKp46+ Cells in the Gut Express RORgt and IL-22diarrhea (+1), soft stool (+2), liquid stool (+3), no blood (+1), bloody stool (+2),
weight gain (+1), weight stable (+2), weight loss between 1%–3% (+3), weight
loss > 3% (+4).
Tissue Preparation and Histological Analysis
Small and large intestines were fixed in 4% paraformaldehyde overnight and
washed in PBS before equilibration with sucrose and embedding in OCT.
Immunostaining was performed as described (Lochner et al., 2008).
SUPPLEMENTAL DATA
Supplemental Data include three figures and can be found with this article
online at http://www.immunity.com/supplemental/S1074-7613(08)00504-9.
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